Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma

NCT05504603 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Untreated Mantle Cell Lymphoma

Interventions

DRUG: zanubrutinib and rituximab
DRUG: zanubrutinib and rituximab
DRUG: BEAM pretreatment
DRUG: zanubrutinib maintenance

Sponsor

The First Affiliated Hospital of Soochow University